Literature DB >> 33442418

LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis.

Jinlin Jia1, Hongle Li2, Jie Chu1, Jinxiu Sheng1, Chang Wang1, Zimo Jia3, Weiwei Meng4, Huiqing Yin1, Junhu Wan1, Fucheng He1.   

Abstract

Background: Recent researches have pinpointed that long non-coding RNA (lncRNA) was tightly related to the carcinogenesis. However, the function of lncRNA in esophageal cell squamous carcinoma (ESCC) remains to be explored. In the current study, we assessed the expression pattern and the biological function of FAM83A-AS1 in ESCC.
Methods: qRT-PCR was used to detect the expression of FAM83A-AS1, miR-214, and CDC25B expression in ESCC tissues and cell lines. CCK-8, transwell, apoptosis and cell cycle assays were performed to define the function of FAM83A-AS1 in ESCC cells. Furthermore, the regulation of miR-214 by FAM83A-AS1 was defined by qRT- PCR and rescue assays. In addition, the association between CDC25B, miR-214, CDC25B was confirmed by qRT-PCR.
Results: Here, we discovered that FAM83A-AS1 was strongly expressed in ESCC tissues. FAM83A-AS1 abundance was associated with TNM stages and the differentiation grade of ESCC patients. The receiver operating characteristic curve (ROC) analysis indicated the high accuracy of FAM83A-AS1 in ESCC diagnosis. Functionally, inhibiting FAM83A-AS1 repressed cell proliferation, migration, and invasion in ESCC. In addition, we found that FAM83A-AS1 accelerated the cell cycle while inhibited cell apoptosis. Mechanistically, we found that FAM83A-AS1 regulated miR-214 expression, and there was a negative correlation between miR-214 and FAM83A-AS1 in ESCC. Rescue assay indicated that miR-214 could impair the suppressing effect of cell migration induced by FAM83A-AS1 depletion. Furthermore, CDC25B was a direct target of miR-214, and FAM83A-AS1 enhanced CDC25B expression while miR-214 positively CDC25B expression in ESCC. Conclusions: Collectively, we concluded that FAM83A-AS1 facilitated ESCC progression by regulating the miR-214/CDC25B axis. Our study showed FAM83A-AS1 may act as a promising target for ESCC diagnosis and therapy. © The author(s).

Entities:  

Keywords:  CDC25B; ESCC; FAM83A-AS1; lncRNA; miR-214

Year:  2021        PMID: 33442418      PMCID: PMC7797654          DOI: 10.7150/jca.54007

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


  35 in total

1.  Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3.

Authors:  Zi-Qi Zheng; Zhi-Xuan Li; Guan-Qun Zhou; Li Lin; Lu-Lu Zhang; Jia-Wei Lv; Xiao-Dan Huang; Rui-Qi Liu; FoPing Chen; Xiao-Jun He; Jia Kou; Jian Zhang; Xin Wen; Ying-Qin Li; Jun Ma; Na Liu; Ying Sun
Journal:  Cancer Res       Date:  2019-07-22       Impact factor: 12.701

2.  lnCAR: A Comprehensive Resource for lncRNAs from Cancer Arrays.

Authors:  Yueyuan Zheng; Qingxian Xu; Mengni Liu; Huanjing Hu; Yubin Xie; Zhixiang Zuo; Jian Ren
Journal:  Cancer Res       Date:  2019-02-20       Impact factor: 12.701

3.  LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1.

Authors:  Qi-Hua Chen; Bo Li; De-Guo Liu; Biao Zhang; Xian Yang; Ya-Ling Tu
Journal:  Cancer Cell Int       Date:  2020-08-15       Impact factor: 5.722

4.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.

Authors:  Darshan S Chandrashekar; Bhuwan Bashel; Sai Akshaya Hodigere Balasubramanya; Chad J Creighton; Israel Ponce-Rodriguez; Balabhadrapatruni V S K Chakravarthi; Sooryanarayana Varambally
Journal:  Neoplasia       Date:  2017-07-18       Impact factor: 5.715

5.  LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3.

Authors:  Tianyou Liu; Zhiyang Han; Huanyu Li; Yuekun Zhu; Ziquan Sun; Anlong Zhu
Journal:  Mol Cancer       Date:  2018-08-11       Impact factor: 27.401

6.  Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway.

Authors:  Lijun Yang; Yafei Ye; Jie Chu; Jinlin Jia; Yunhui Qu; Ting Sun; Huiqing Yin; Liang Ming; Junhu Wan; Fucheng He
Journal:  Cancer Manag Res       Date:  2019-05-13       Impact factor: 3.989

7.  LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.

Authors:  Qian Hua; Mingming Jin; Baoming Mi; Fei Xu; Tian Li; Li Zhao; Jianjun Liu; Gang Huang
Journal:  J Hematol Oncol       Date:  2019-09-05       Impact factor: 17.388

8.  GEDS: A Gene Expression Display Server for mRNAs, miRNAs and Proteins.

Authors:  Mengxuan Xia; Chun-Jie Liu; Qiong Zhang; An-Yuan Guo
Journal:  Cells       Date:  2019-07-03       Impact factor: 6.600

9.  Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer.

Authors:  Guangbing Xiong; Chang Liu; Gang Yang; Mengyu Feng; Jianwei Xu; Fangyu Zhao; Lei You; Li Zhou; Lianfang Zheng; Ya Hu; Xiaowo Wang; Taiping Zhang; Yupei Zhao
Journal:  J Hematol Oncol       Date:  2019-09-12       Impact factor: 17.388

10.  A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1.

Authors:  Erbao Zhang; Xuezhi He; Chongguo Zhang; Jun Su; Xiyi Lu; Xinxin Si; Jinfei Chen; Dandan Yin; Liang Han; Wei De
Journal:  Genome Biol       Date:  2018-10-04       Impact factor: 13.583

View more
  9 in total

1.  FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKɑ signaling in lung adenocarcinoma.

Authors:  Huijie Zhao; Yinghan Wang; Xing Wu; Xaofei Zeng; Baoyue Lin; Shengmin Hu; Shenglin Zhang; Yu Li; Zhiqing Zhou; Yujie Zhou; Changzheng Du; David G Beer; Shengbin Bai; Guoan Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.

Authors:  Zhencong Chen; Zhengyang Hu; Qihai Sui; Yiwei Huang; Mengnan Zhao; Ming Li; Jiaqi Liang; Tao Lu; Cheng Zhan; Zongwu Lin; Fenghao Sun; Qun Wang; Lijie Tan
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

3.  Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.

Authors:  Hongyu Huang; Chuyi Yang; Qichen Zhang; Ting Zhuo; Xiaohong Li; Nijiao Li; Lu Zhu; Chenyang Luo; Jinyan Gan; Yanbin Wu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

4.  A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma.

Authors:  Jiahang Song; Yuanyuan Sun; Hui Cao; Zhengcheng Liu; Lei Xi; Changqing Dong; Rusong Yang; Ye Shi
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 5.  A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response.

Authors:  Uttam Sharma; Masang Murmu; Tushar Singh Barwal; Hardeep Singh Tuli; Manju Jain; Hridayesh Prakash; Tea Kaceli; Aklank Jain; Anupam Bishayee
Journal:  Curr Oncol       Date:  2022-03-26       Impact factor: 3.109

6.  A two-phase comprehensive NSCLC prognostic study identifies lncRNAs with significant main effect and interaction.

Authors:  Jing Zhu; Jinxing Guan; Xinyu Ji; Yunjie Song; Xiaoshuang Xu; Qianqian Wang; Quanan Zhang; Renhua Guo; Rui Wang; Ruyang Zhang
Journal:  Mol Genet Genomics       Date:  2022-02-26       Impact factor: 3.291

7.  Comprehensive Analysis and Experimental Validation of a Novel Estrogen/Progesterone-Related Prognostic Signature for Endometrial Cancer.

Authors:  Jing Yu; Hong-Wen Yao; Ting-Ting Liu; Di Wang; Jian-Hong Shi; Guang-Wen Yuan; Sai Ma; Ling-Ying Wu
Journal:  J Pers Med       Date:  2022-05-31

8.  Necroptosis-related lncRNA in lung adenocarcinoma: A comprehensive analysis based on a prognosis model and a competing endogenous RNA network.

Authors:  Fuling Mao; Zihao Li; Yongwen Li; Hua Huang; Zijian Shi; Xuanguang Li; Di Wu; Hongyu Liu; Jun Chen
Journal:  Front Genet       Date:  2022-09-08       Impact factor: 4.772

9.  Web tools to perform long non-coding RNAs analysis in oncology research.

Authors:  Shixing Gu; Guangjie Zhang; Qin Si; Jiawen Dai; Zhen Song; Yingshuang Wang
Journal:  Database (Oxford)       Date:  2021-07-23       Impact factor: 3.451

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.